Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Bolyn Hubby, Ph.D., Executive Vice President and Chief Corporate Affairs Officer, will...
Prometheus Biosciences to Participate at the Cowen 42nd Annual Healthcare Conference
March 01, 2022 08:30 ET
|
Prometheus Biosciences
SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2022
March 01, 2022 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., March 01, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...
Apellis Pharmaceuticals to Present at the Cowen 39th Annual Health Care Conference
March 04, 2019 16:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM Mass. and CRESTWOOD, Ky., March 04, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel...
Kiniksa Pharmaceuticals to Present at the Cowen and Company 39th Annual Healthcare Conference
February 28, 2019 07:30 ET
|
Kiniksa Pharmaceuticals, Ltd.
HAMILTON, Bermuda, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the Cowen and Company 39th Annual Healthcare Conference on...
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
February 23, 2018 07:00 ET
|
Apellis Pharmaceuticals, Inc.
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel...